For years, China’s real estate market was booming. Developers, home buyers and Western banks rushed to invest. But the boom turned into a bubble, which eventually burst. WSJ’s Rebecca Feng reports on the warning signs that were ignored and we speak to two people who saw the collapse coming.  Further Reading: -The Folly of China’s Real-Estate Boom Was Easy to See, but No One Wanted to Stop It-Evergrande Was Once China’s Biggest Property Developer. Now, It Has Been Ordered to Liquidate.  Further Listening: -China’s Property Market Crisis  -China’s Evergrande Crisis  Learn more about your ad choices. Visit megaphone.fm/adchoices

Assistant Attorney General Jonathan Kanter heads the Department of Justice’s Antitrust Division. He speaks with Ryan Knutson about the DOJ’s lawsuit against Live Nation and Ticketmaster, and why the government says the business is an illegal monopoly which the company denies. Further Reading: - Justice Department to Sue Live Nation, Seek Breakup of Concert and Ticketing Giant  - Justice Department Sues to Break Up Live Nation-Ticketmaster  Further Listening: - The Taylor Swift Ticketmaster Debacle  Learn more about your ad choices. Visit megaphone.fm/adchoices

For over a century, the NCAA has refused to pay athletes. After a recent settlement, that’s going to change. The organization has agreed to set aside $2.8 billion in back payments for some student athletes and moving forward, allow players to get a cut of television revenue. WSJ’s Jared Diamond explains what it might mean for the future of college athletics. Further Reading: -NCAA Agrees to Share Revenue With Athletes in Landmark $2.8 Billion Settlement  -He Was the $13 Million QB Recruit. Now He’s Suing the Boosters Who Never Paid Up.  Further Listening: -Why an Ivy League Basketball Team Voted to Unionize  -The TikTok That Changed College Hoops  Learn more about your ad choices. Visit megaphone.fm/adchoices

Trillion Dollar Shot, our new series about drugs like Ozempic, will be back next week. Until then, we think you’d enjoy a show from our friends over at Science Vs, a podcast that takes on fads, trends and the opinionated mob to find out what’s fact, what’s not and what’s somewhere in between. This episode examines the fears around the new class of blockbuster weight-loss drugs. This episode does deal with depression and suicidal thoughts. If you are in the U.S. and need help, dial 988. Full list of international hotlines here.  Learn more about your ad choices. Visit megaphone.fm/adchoices